SCHEMBL31548745

SCHEMBL31548745

CC(C)(C)OC(=O)N1CC(N2CCC(c3ccc(-c4cc(-c5ccccc5O)nnc4N)cc3)CC2)C1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PBRM1 Q86U86 9/20 0.57
▸ SMARCA2 P51531 8/20 0.57
▸ SMARCA4 P51532 8/20 0.57
▸ BRD4 O60885 2/20 0.44
▸ NR1I2 O75469 2/20 0.44
▸ SRC P12931 4/20 0.42
▸ EGFR P00533 2/20 0.42
▸ JAK2 O60674 2/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ PTK2 Q05397 2/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ ABL1 P00519 1/20 0.40
▸ ABL2 P42684 1/20 0.40
▸ CCNT1 O60563 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ P2RY14 Q15391 1/20 0.39
▸ RET P07949 1/20 0.39
▸ NR1H2 P55055 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31548738 0.91 SMARCA2 (0.65) PBRM1SMARCA2SMARCA4BRD4NR1I2
SCHEMBL31548731 0.84 SMARCA2 (0.46) PBRM1SMARCA2SMARCA4BRD4NR1I2
SCHEMBL30520304 0.82 SMARCA2 (0.50) PBRM1SMARCA2SMARCA4BRD4NR1I2
SCHEMBL25345477 0.82 SMARCA2 (0.50) PBRM1SMARCA2SMARCA4BRD4NR1I2
SCHEMBL31548779 0.82 SMARCA2 (0.57) PBRM1SMARCA2SMARCA4BRD4NR1I2
SCHEMBL30796907 0.79 SMARCA2 (0.61) PBRM1SMARCA2SMARCA4NR1I2JAK2
SCHEMBL27461726 0.79 SMARCA2 (0.61) PBRM1SMARCA2SMARCA4NR1I2JAK2
SCHEMBL18038859 0.79 PBRM1 (0.66) PBRM1SMARCA2SMARCA4BRD4NR1I2
SCHEMBL30606896 0.79 PBRM1 (0.66) PBRM1SMARCA2SMARCA4BRD4NR1I2
SCHEMBL22776665 0.79 SMARCA2 (0.58) PBRM1SMARCA2SMARCA4BRD4NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025094065-A1 AMINO-SUBSTITUTED PYRIDAZINE COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS AURIGENE ONCOLOGY LIMITED (IN) 2025-05-08 — — WO disclosed
Send feedback